BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 19094423)

  • 1. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
    Huang K; Wu LD
    J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.
    Verma P; Dalal K
    J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review.
    Bondeson J; Wainwright S; Hughes C; Caterson B
    Clin Exp Rheumatol; 2008; 26(1):139-45. PubMed ID: 18328163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aggrecanases and osteoarthritis].
    Li C; Cao YP; Guan ZP; Huang de Y; Ge ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):611-2. PubMed ID: 19829688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis].
    Ji Q; Zhang Q; Wang Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1080-4. PubMed ID: 24279019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
    Troeberg L; Fushimi K; Khokha R; Emonard H; Ghosh P; Nagase H
    FASEB J; 2008 Oct; 22(10):3515-24. PubMed ID: 18632849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug insight: aggrecanases as therapeutic targets for osteoarthritis.
    Fosang AJ; Little CB
    Nat Clin Pract Rheumatol; 2008 Aug; 4(8):420-7. PubMed ID: 18577998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis?
    Huang K; Wu LD
    Mol Biol Rep; 2010 Mar; 37(3):1241-5. PubMed ID: 19277895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cleavage of biglycan by aggrecanases.
    Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
    Struglics A; Hansson M
    Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggrecanases in the human synovial fluid at different stages of osteoarthritis.
    Zhang E; Yan X; Zhang M; Chang X; Bai Z; He Y; Yuan Z
    Clin Rheumatol; 2013 Jun; 32(6):797-803. PubMed ID: 23370724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
    Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
    Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of human neutralizing antibody to ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2).
    Shiraishi A; Mochizuki S; Miyakoshi A; Kojoh K; Okada Y
    Biochem Biophys Res Commun; 2016 Jan; 469(1):62-69. PubMed ID: 26612259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition.
    Cuffaro D; Ciccone L; Rossello A; Nuti E; Santamaria S
    J Med Chem; 2022 Oct; 65(20):13505-13532. PubMed ID: 36250680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
    Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
    Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration.
    Patel KP; Sandy JD; Akeda K; Miyamoto K; Chujo T; An HS; Masuda K
    Spine (Phila Pa 1976); 2007 Nov; 32(23):2596-603. PubMed ID: 17978660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
    Nuti E; Santamaria S; Casalini F; Yamamoto K; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Marini AM; Salerno S; Taliani S; Da Settimo F; Nagase H; Rossello A
    Eur J Med Chem; 2013 Apr; 62():379-94. PubMed ID: 23376997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nobiletin, a citrus polymethoxy flavonoid, suppresses gene expression and production of aggrecanases-1 and -2 in collagen-induced arthritic mice.
    Imada K; Lin N; Liu C; Lu A; Chen W; Yano M; Sato T; Ito A
    Biochem Biophys Res Commun; 2008 Aug; 373(2):181-5. PubMed ID: 18541144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggrecanases and cartilage matrix degradation.
    Nagase H; Kashiwagi M
    Arthritis Res Ther; 2003; 5(2):94-103. PubMed ID: 12718749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc.
    Wang J; Markova D; Anderson DG; Zheng Z; Shapiro IM; Risbud MV
    J Biol Chem; 2011 Nov; 286(46):39738-49. PubMed ID: 21949132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.